study,treatment,responders,sampleSize,rob,ind
Anstee QM 2024,Cenicriviroc,38,859,1,1
Anstee QM 2024,Placebo,16,429,1,1
Friedman SL; Ratziu V 2018,Cenicriviroc,9,144,1,1
Friedman SL; Ratziu V 2018,Placebo,10,144,1,1
Harrison SA 2018,Aldafermin,6,55,1,1
Harrison SA 2018,Placebo,0,27,1,1
Harrison SA 2021a,Aldafermin,0,53,1,1
Harrison SA 2021a,Placebo,1,25,1,1
Harrison SA 2022,Aldafermin,10,127,1,1
Harrison SA 2022,Placebo,3,43,1,1
Harrison SA 2021b,Efruxifermin,6,58,1,1
Harrison SA 2021b,Placebo,1,21,1,1
Harrison SA 2023a,Efruxifermin,10,83,2,1
Harrison SA 2023a,Placebo,0,43,2,1
Loomba R 2023a,Pegbelfermin,4,148,1,1
Loomba R 2023a,Placebo,3,49,1,1
Loomba R 2023b,Pegozafermin,8,150,1,1
Loomba R 2023b,Placebo,1,69,1,1
Loomba R 2023c,Pegozafermin,2,63,1,1
Loomba R 2023c,Placebo,0,18,1,1
Sanyal A 2019,Pegbelfermin,0.5,49,1,1
Sanyal A 2019,Placebo,0,26,1,1
Anstee QM 2023,Tropifexor,9,50,1,1
Anstee QM 2023,Cenicriviroc,3,48,1,1
Anstee QM 2023,Tropifexor + Cenicriviroc,9,95,1,1
Patel K 2020,Cilofexor,6,112,2,1
Patel K 2020,Placebo,2,28,2,1
Ratziu V 2023-B,Vonafexor,12,64,1,1
Ratziu V 2023-B,Placebo,0,32,1,1
Sanyal A 2023-A+B,Tropifexor,5,152,1,1
Sanyal A 2023-A+B,Placebo,1,46,1,1
Sanyal A 2023-C,Tropifexor,14,101,1,1
Sanyal A 2023-C,Placebo,2,51,1,1
Younossi ZM; Ratziu V 2019,Obeticholic acid,122,1311,1,1
Younossi ZM; Ratziu V 2019,Placebo,41,657,1,1
Armstrong MJ 2016,Liraglutide,2,26,1,1
Armstrong MJ 2016,Placebo,1,26,1,1
Alkhouri N 2022,Semaglutide,3,21,3,1
Alkhouri N 2022,Semaglutide + Cilofexor,2,44,3,1
Alkhouri N 2022,Semaglutide + Firsocostat,2,22,3,1
Alkhouri N 2022,Semaglutide + Cilofexor + Firsocostat,1,21,3,1
Newsome PN 2021,Semaglutide,17,239,1,1
Newsome PN 2021,Placebo,4,80,1,1
Francque SM 2021,Lanifibranor,7,166,1,1
Francque SM 2021,Placebo,3,81,1,1
Gawrieh S 2021,Saroglitazar,3,78,1,1
Gawrieh S 2021,Placebo,0,28,1,1
Ratziu V 2016,Elafibranor,12,182,1,1
Ratziu V 2016,Placebo,6,92,1,1
Aithal GP 2008,Pioglitazone,6,37,1,1
Aithal GP 2008,Placebo,7,37,1,1
Cusi K 2016,Pioglitazone,0,50,1,1
Cusi K 2016,Placebo,1,51,1,1
Harrison SA 2020,MSDC-0602K,6,298,1,1
Harrison SA 2020,Placebo,4,94,1,1
Harrison SA 2023b,PXL065,1,87,1,1
Harrison SA 2023b,Placebo,1,30,1,1
"Huang, Jee-Fu 2021",Pioglitazone,2,43,1,1
"Huang, Jee-Fu 2021",Placebo,1,47,1,1
Ratziu V 2008,Rosiglitazone,1,32,1,1
Ratziu V 2008,Placebo,0,31,1,1
Harrison SA 2023c,Resmetirom,20,822,1,1
Harrison SA 2023c,Placebo,4,318,1,1
Harrison SA 2024,Resmetirom,34,645,1,1
Harrison SA 2024,Placebo,11,321,1,1